These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1637073)

  • 1. Cholinergic toxins and Alzheimer's disease.
    Hanin I
    Ann N Y Acad Sci; 1992 May; 648():63-70. PubMed ID: 1637073
    [No Abstract]   [Full Text] [Related]  

  • 2. AF64A-induced brain damage and its relation to dementia.
    Hörtnagl H
    J Neural Transm Suppl; 1994; 44():245-57. PubMed ID: 7897396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene.
    Cha Y; Lee SH; Jang SK; Guo H; Ban YH; Park D; Jang GY; Yeon S; Lee JY; Choi EK; Joo SS; Jeong HS; Kim YB
    Toxicol Appl Pharmacol; 2017 Jan; 314():48-54. PubMed ID: 27871887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral injections of AF64A: an animal model of Alzheimer's disease?
    Jarrard LE; Levy A; Meyerhoff JL; Kant GJ
    Ann N Y Acad Sci; 1985; 444():520-2. PubMed ID: 3860115
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effect of NT-0409 and antidementia drugs on learning and memory in rats with chronic cerebral cholinergic deficiency.
    Lermontova NN; Mukhina TV; Van'kin GI; Serkova TP; Bachurin SO
    Bull Exp Biol Med; 2003 Jan; 135(1):48-51. PubMed ID: 12717512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen on AF64A-induced apoptosis in NG108-15 cells.
    Kuwagata Y; Inoue H
    Brain Res; 2009 Nov; 1297():9-16. PubMed ID: 19729002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
    Fisher A; Hanin I
    Annu Rev Pharmacol Toxicol; 1986; 26():161-81. PubMed ID: 3087271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
    Dudas B; Hanin I; Rose M; Wülfert E
    Neurobiol Dis; 2004 Mar; 15(2):262-8. PubMed ID: 15006696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic models of Alzheimer's disease.
    Patel S; Tariot PN
    Psychiatr Clin North Am; 1991 Jun; 14(2):287-308. PubMed ID: 2062722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
    Rose M; Dudas B; Cornelli U; Hanin I
    Brain Res; 2004 Jul; 1015(1-2):96-102. PubMed ID: 15223371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A).
    Gulyaeva NV; Lazareva NA; Libe ML; Mitrokhina OS; Onufriev MV; Stepanichev MYu ; Chernysevskaya IA; Walsh TJ
    Brain Res; 1996 Jul; 726(1-2):174-80. PubMed ID: 8836558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroplasticity, the aging brain, and Alzheimer's disease.
    Walsh TJ; Opello KD
    Neurotoxicology; 1992; 13(1):101-10. PubMed ID: 1508410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease.
    Bartolomeo AC; Morris H; Boast CA
    Neurobiol Learn Mem; 1997 Nov; 68(3):333-42. PubMed ID: 9398593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic markers in the early diagnosis of Alzheimer's disease.
    Jenden DJ
    Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
    Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
    Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific toxic effects of ethylcholine nitrogen mustard on cholinergic neurons of the nucleus basalis of Meynert.
    Kozlowski MR; Arbogast RE
    Brain Res; 1986 Apr; 372(1):45-54. PubMed ID: 3708359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic neurotoxicity induced by ethylcholine aziridinium (AF64A) in neuron-enriched cultures.
    Davies DL; Sakellaridis N; Valcana T; Vernadakis A
    Brain Res; 1986 Jul; 378(2):251-61. PubMed ID: 3730876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of peripheral cholinergic transmission in the cat produced by AF64A.
    Mantione CR; deGroat WC; Fisher A; Hanin I
    J Pharmacol Exp Ther; 1983 Jun; 225(3):616-22. PubMed ID: 6306213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.